&l;p&g;&l;a href=&q;https://blogs.forbes.com/bradthomas/files/2018/03/upq.jpg&q; target=&q;_blank&q;&g;&l;img class=&q;size-medium wp-image-2920&q; src=&q;http://blogs-images.forbes.com/bradthomas/files/2018/03/upq-300×186.jpg?width=960&q; alt=&q;&q; data-height=&q;186&q; data-width=&q;300&q;&g;&l;/a&g; Source: Pexels
Some analysts use the term &q;strong buy&q;&a;nbsp;to get page views or excite readers, but I consider a strong buy to mean the following:
&l;/p&g;&l;blockquote&g;&l;strong&g;&a;ldquo;Strong Buy&l;/strong&g;&a;nbsp;means that I am recommending a high-quality REIT that is trading at a wider margin of safety. Recognizing principal preservation is critical, my recommendation is telegraphing readers that the company is a blue chip on sale.&a;rdquo;&l;/blockquote&g;
In my monthly newsletter (&l;em&g;Forbes&l;/em&g; Real Estate Investor) I have labeled six REITs as strong buys and I just upgraded two others (as &l;span&g;strong buy&l;/span&g;s). As we enter 2018, most analysts have suspected that the fear of rising rates had already been priced in and nobody (including me) suspected that there would be an extreme February selloff in REIT-land.
Best Blue Chip Stocks For 2018: TESARO, Inc.(TSRO)
- [By Paul Ausick]
Tesaro Inc. (NASDAQ: TSRO) dropped about 9.5% Tuesday to post a 52-week low of $63.00 after closing at $69.59 on Friday. The 52-week high is $192.94. Volume was around 2.6 million, nearly triple the daily average. The company had no specific news, but a couple of shareholder lawsuits were announced.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Tesaro (TSRO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Paul Ausick]
Tesaro Inc. (NASDAQ: TSRO) traded down about 10% Tuesday and posted a new 52-week low of $74.57 after Friday at $82.87. The 52-week high is $192.94. Volume was about 2 million, more than double the daily average of around 870,000 million shares. The maker of cancer therapeutics had no specific news.
- [By Chris Lange]
Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.
- [By Ethan Ryder]
Shares of Tesaro (NASDAQ:TSRO) rose 6.2% during trading on Monday . The stock traded as high as $57.99 and last traded at $55.51. Approximately 1,596,660 shares were traded during trading, an increase of 37% from the average daily volume of 1,167,780 shares. The stock had previously closed at $52.26.
Best Blue Chip Stocks For 2018: Fortress Transportation and Infrastructure Investors LLC(FTAI)
- [By Logan Wallace]
These are some of the media stories that may have effected Accern Sentiment’s scoring:
Fortress Transportation and Infrastructure Investors (FTAI) Lifted to B- at TheStreet (americanbankingnews.com) BidaskClub Upgrades Fortress Transportation and Infrastructure Investors (FTAI) to “Buy” (americanbankingnews.com) Active Mover Fortress Transportation and Infrastructure Investors LLC (NYSE: FTAI) (alphabetastock.com) Services Stock Buzz: Fortress Transportation and Infrastructure Investors LLC (FTAI) (stocksgeeks.com) Contrasting H&E Equipment Services (HEES) & Fortress Transportation and Infrastructure Investors (FTAI) (americanbankingnews.com)
Shares of FTAI opened at $16.25 on Friday. The stock has a market cap of $1,365.03, a PE ratio of 135.42 and a beta of 1.56. Fortress Transportation and Infrastructure Investors has a 12-month low of $14.25 and a 12-month high of $20.13.
Best Blue Chip Stocks For 2018: Cerus Corporation(CERS)
- [By Lisa Levin] Gainers
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
Gulfport Energy Corporation (NASDAQ: GPOR)
- [By Cory Renauer]
Shares of Cerus Corporation(NASDAQ:CERS),a biomedical products company, are on the move following a healthy first-quarter earnings report. Strong demand for its platelet kits encouraged the company to boost forward guidance. Investors liked what they heard and pushed the stock 16.5% higher as of 12:47 p.m. EDT on Wednesday.